Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2026-01-10 @ 8:57 PM
Study NCT ID:
NCT05420961
Status:
COMPLETED
Last Update Posted:
2024-10-26
First Post:
2022-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-13
First Submit QC Date:
None
Study First Post Date:
2022-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-04
Results First Submit QC Date:
None
Results First Post Date:
2024-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL